Stockholm-based contract development and manufacturing organization for pharmaceutical products in several dosage forms.
Recipharm AB is a contract development and manufacturing organization for the pharmaceutical industry, based in Stockholm, Sweden. It was founded by Lars Backsell and Thomas Eldered in 1995, and its services include drug substance and drug product development, analytical chemistry, and manufacturing and packaging of clinical trial material. In March 2021, EQT and the company's management fully acquired Recipharm AB for SEK 17.929 billion in a public-to-private deal. Greg Behar was CEO as of 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in